|Page (1) of 1 - 03/22/11||email article||print page|
BioPharm Systems Achieves Oracle PartnerNetwork Gold Specializations for Argus Safety and Siebel Clinical(March 22, 2011)
Oracle's Specialized status provides customers with proof that they will be engaging with a knowledgeable and experienced partner who has expertise in specific products and is able to work with them to implement and use these solutions.
Achieving Specialization in two products demonstrates BioPharm Systems' proficiency in Oracle's clinical trial management and pharmacovigilance systems, as well as its commitment to Oracle Health Sciences solutions. "Our dedication to Oracle and our clients is exceptionally strong, which is why this Specialization status is so important to us," said Alex Sefanov, president and CEO of BioPharm Systems. "We believe that Oracle's PV and CTMS applications are the best ones on the market, and we are confident that our clients will get the most benefit from these state-of-the-art systems compared to anything else available today in our industry."
About BioPharm Systems
BioPharm Systems (www.biopharm.com) is an IT consulting company that focuses on the life sciences industry. We have extensive experience in the implementation, integration, migration, and hosting of Oracle's clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, and electronic data capture systems. Our products and services help accelerate the development of new drugs, devices, and other therapies.
Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company's products and services, please call +1 877 654 0033 or e-mail firstname.lastname@example.org.
North America Sales Contact:
+1 877 654 0033
Europe/Middle East/Africa Sales Contact:
+44 (0) 1865 910200
+1 617 795 2032
Related Keywords:siebel clinical, argus safety, clinical trial management system, oracle, drug safety, pharmacovigilance, regulatory affairs, risk management